SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-067846
Filing Date
2020-05-29
Accepted
2020-05-29 17:07:39
Documents
3
Period of Report
2020-05-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2021120d1_8k.htm 8-K 26515
2 EXHIBIT 99.1 tm2021120d1_ex99-1.htm EX-99.1 16052
3 GRAPHIC image_001.jpg GRAPHIC 3966
  Complete submission text file 0001104659-20-067846.txt   49382
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 20929124
SIC: 2836 Biological Products, (No Diagnostic Substances)